Dr. Bullock has over 10 years of drug development experience within the FDA. Dr. Bullock’s past appointments include Clinical Pharmacology Team Leader and Senior Clinical Pharmacology Reviewer (FDA).
Her regulatory experience was focused in the therapeutic areas of hematology/oncology and coagulation. She has unique insight in pediatric development, PK/PD approaches for biosimilar products, oncology dose finding strategy and streamlining development for breakthrough therapies and accelerated approval.
Dr. Bullock has contributed to over 14 new molecular entity approvals during her 10 year FDA career.